Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dong-A Pharma is a leading South Korean healthcare company specializing in over-the-counter (OTC) drugs, consumer health products, and oral care. As a core subsidiary of Dong-A Socio Holdings, it manages iconic Korean brands such as Bacchus, the country's top-selling energy drink, and various digestive and cold remedies. The company focuses on enhancing public health through a diverse portfolio that includes medicines, medical devices, and quasi-drugs. While its sister company, Dong-A ST, handles prescription pharmaceuticals and advanced R&D, Dong-A Pharma dominates the domestic consumer-facing healthcare market. The broader Dong-A Socio Group is actively expanding its global footprint through subsidiaries like NeuroBo Pharmaceuticals, focusing on metabolic diseases and oncology. Dong-A Pharma maintains state-of-the-art manufacturing facilities in Cheonan and Icheon, adhering to strict GMP standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dong-A Pharma.